These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8467748)

  • 21. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Glintborg B
    Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azathioprine in Crohn's disease.
    Rhodes J; Bainton D; Beck P
    Lancet; 1970 Nov; 2(7683):1142. PubMed ID: 4097954
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintenance azathioprine in Crohn's disease.
    Kitis G
    Lancet; 1978 Dec; 2(8103):1306. PubMed ID: 82802
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 26. Steering azathioprine safely: lessons from pharmacogenetics.
    Aithal GP; Hoffman BJ
    Am J Gastroenterol; 2001 Nov; 96(11):3202-3. PubMed ID: 11721776
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab].
    Martín De Carpi J; Varea V
    An Pediatr (Barc); 2009 Mar; 70(3):271-7. PubMed ID: 19409244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV
    Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natalizumab (Tysabri) returns.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289
    [No Abstract]   [Full Text] [Related]  

  • 31. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
    Pinto AL; Chebli LA; Ribeiro MS; Pace FH; Moraes JP; do Amaral FJ; Gaburri PD; Meirelles de Souza AF; Chebli JM
    Med Sci Monit; 2009 May; 15(5):PI19-26. PubMed ID: 19396048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
    Mossop H; Davies P; Murphy MS
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine.
    Castiglione F; Del Vecchio Blanco G; Rispo A; Mazzacca G
    Am J Gastroenterol; 2000 Sep; 95(9):2394-5. PubMed ID: 11007256
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute episode].
    Schölmerich J;
    Z Gastroenterol; 2003 Jan; 41(1):27-30. PubMed ID: 12541170
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current medical treatment of inflammatory bowel disease].
    Bosques-Padilla F
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of varicella infection during the course of inflammatory bowel disease.
    Mouzas IA; Greenstein AJ; Giannadaki E; Balasubramanian S; Manousos ON; Sachar DB
    Am J Gastroenterol; 1997 Sep; 92(9):1534-7. PubMed ID: 9317080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
    Pozler O; Maly J; Bonova O; Dedek P; Frühauf P; Havlickova A; Janatova T; Jimramovsky F; Klimova L; Klusacek D; Kocourkova D; Kolek A; Kotalova R; Marx D; Nevoral J; Petro R; Petru O; Plasilova I; Seidl Z; Sekyrova I; Semendak N; Schreierova I; Stanek J; Sykora J; Sulakova A; Toukalkova L; Travnickova R; Volf V; Zahradnicek L; Zenisková I
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):186-9. PubMed ID: 16456413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
    Francolla KA; Altman A; Sylvester FA
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):193-5. PubMed ID: 18664872
    [No Abstract]   [Full Text] [Related]  

  • 39. Azathioprine: an adjunct to surgical therapy of granulomatous enteritis.
    Drucker WR; Jeejeebhoy KN
    Ann Surg; 1970 Oct; 172(4):618-26. PubMed ID: 5458618
    [No Abstract]   [Full Text] [Related]  

  • 40. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC; Butler WJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.